These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31473116)

  • 1. A Case-Based Discussion on the Management of Cryptogenic Stroke and Patent Foramen Ovale in the Patient With a Hypercoagulable Disorder.
    Gerstein NS; Clegg SD; Levin DB; Fish AC; Tolstrup K; Nakanishi K; Yoshida Y; Homma S
    J Cardiothorac Vasc Anesth; 2019 Dec; 33(12):3476-3485. PubMed ID: 31473116
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrent Paradoxical and Pulmonary Embolism, Hypercoagulable State, and Patent Foramen Ovale.
    Naqvi SY; Sadiq A; Goldberg S
    Circulation; 2016 Jan; 133(3):337-40. PubMed ID: 26783277
    [No Abstract]   [Full Text] [Related]  

  • 3. Patent foramen ovale and cryptogenic stroke: many unanswered questions.
    Roth C; Alli O
    Cleve Clin J Med; 2014 Jul; 81(7):417-24. PubMed ID: 24987042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right-to-left shunt and the hypercoagulable state: does paradoxical embolism play a role in patients with antiphospholipid syndrome and stroke?
    Zamproni LN; Zétola VF; Lange MC
    Arq Neuropsiquiatr; 2012 Aug; 70(8):578-82. PubMed ID: 22899027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of patent foramen ovale determined by transesophageal echocardiography in patients with cryptogenic stroke aged 55 years or older. Same as younger patients?
    Mesa D; Ruiz M; Delgado M; Suárez de Lezo J; Pan M; Tejero I; García D; Crespín M; León C; Toledano F; Mazuelos F; Ochoa JJ; Bescansa E
    Rev Esp Cardiol; 2010 Mar; 63(3):315-22. PubMed ID: 20196992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and a high prevalence of abnormalities on comprehensive arterial and venous thrombophilia screening in TIA or ischaemic stroke patients with a patent foramen ovale, an inter-atrial septal aneurysm or both.
    Lim ST; Murphy SJX; Smith DR; Williams J; Navarro SG; McCabe J; Moore DP; McHugh J; McCabe DJH
    J Neurol Sci; 2017 Jun; 377():227-233. PubMed ID: 28477701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of atrial fibrillation after percutaneous closure of patent foramen ovale and small atrial septal defects in patients presenting with cryptogenic stroke.
    Bonvini RF; Sztajzel R; Dorsaz PA; Righini M; Bonvin C; Alibegovic J; Sigwart U; Camenzind E; Verin V; Sztajzel J
    Int J Stroke; 2010 Feb; 5(1):4-9. PubMed ID: 20088986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which Patent Foramen Ovales Need Closure to Prevent Cryptogenic Strokes?
    Dalen JE; Alpert JS
    Am J Med; 2018 Mar; 131(3):222-225. PubMed ID: 29175238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term risk of recurrent stroke in young cryptogenic stroke patients with and without patent foramen ovale.
    Arauz A; Murillo L; Márquez JM; Tamayo A; Cantú C; Roldan FJ; Vargas-Barrón J; Barinagarrementeria F
    Int J Stroke; 2012 Dec; 7(8):631-4. PubMed ID: 21978242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombophilia in young patients with cryptogenic stroke and patent foramen ovale (PFO).
    Offelli P; Zanchetta M; Pedon L; Marzot F; Cucchini U; Pegoraro C; Iliceto S; Pengo V
    Thromb Haemost; 2007 Oct; 98(4):906-7. PubMed ID: 17938820
    [No Abstract]   [Full Text] [Related]  

  • 11. Patent foramen ovale and cryptogenic stroke in older patients.
    Handke M; Harloff A; Olschewski M; Hetzel A; Geibel A
    N Engl J Med; 2007 Nov; 357(22):2262-8. PubMed ID: 18046029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral thalamic stroke in patient with patent foramen ovale and hereditary thrombophilia.
    Brovko MY; Akulkina LA; Sholomova VI; Yanakayeva AS; Strizhakov LA; Lebedeva MV; Zakharov VV; Volkov AV; Lazareva AV; Kinkul'kina MA; Ivanets NN; Fomin VV
    Ter Arkh; 2018 Nov; 90(11):62-66. PubMed ID: 30701817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Closure of patent foramen ovale for cryptogenic stroke patients: an updated systematic review and meta-analysis of randomized trials.
    Niu X; Ou-Yang G; Yan PF; Huang SL; Zhang ZT; Zhang ZH
    J Neurol; 2018 Jun; 265(6):1259-1268. PubMed ID: 29383514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombus in a Hypercoagulable Patient Following Patent Foramen Ovale Closure With the Gore Septal Occluder.
    Luc JGY; Bakar SN; Kiaii B; Sridhar K
    JACC Cardiovasc Interv; 2018 Jun; 11(11):1108-1109. PubMed ID: 29778728
    [No Abstract]   [Full Text] [Related]  

  • 15. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.
    Lee PH; Song JK; Kim JS; Heo R; Lee S; Kim DH; Song JM; Kang DH; Kwon SU; Kang DW; Lee D; Kwon HS; Yun SC; Sun BJ; Park JH; Lee JH; Jeong HS; Song HJ; Kim J; Park SJ
    J Am Coll Cardiol; 2018 May; 71(20):2335-2342. PubMed ID: 29544871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study.
    Kasner SE; Thomassen L; Søndergaard L; Rhodes JF; Larsen CC; Jacobson J
    Int J Stroke; 2017 Dec; 12(9):998-1004. PubMed ID: 29090661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NobleStitch Patent Foramen Ovales Closure for Recurrent Strokes in a Patient with COVID-19 on Extracorporeal Membrane Oxygenation.
    Stout PA; Tabrizi NS; Tribble M; Richvalsky T; Youn C; Md BW; Shapeton AD; Musuku SR
    J Cardiothorac Vasc Anesth; 2023 Feb; 37(2):261-265. PubMed ID: 36372721
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of patent foramen ovale in cryptogenic stroke.
    Budts W; Legrand V; Peeters A; Thijs V
    Acta Cardiol; 2012 Feb; 67(1):3-9. PubMed ID: 22455084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous device closure of patent foramen ovale in patients with presumed cryptogenic stroke or transient ischemic attack: the Mayo Clinic experience.
    Ford MA; Reeder GS; Lennon RJ; Brown RD; Petty GW; Cabalka AK; Cetta F; Hagler DJ
    JACC Cardiovasc Interv; 2009 May; 2(5):404-11. PubMed ID: 19463462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is patent foramen ovale closure an OPTION in patients with cryptogenic stroke? An Italian multicentre registry proposal.
    Faggiano P; Toni D; Strano S; Seccareccia F
    J Cardiovasc Med (Hagerstown); 2014 Oct; 15(10):769-70. PubMed ID: 25162175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.